Zywie Selected for Startup Showcase at 10th Annual Venture Atlanta

Published on:

ATLANTA, Sept. 14, 2017 (GLOBE NEWSWIRE)—Zywie, a health IT company using technology to improve the early detection and precise remote monitoring of patients with cardiovascular disease (CVD), has been selected to participate in the Startup Showcase at the 2017 Venture Atlanta. The 10th annual event will be held October 11-12 at the College Football Hall of Fame in Atlanta.

Zywie is revolutionizing cardiac remote monitoring with its innovative solution that improves patient care and value to the physician. ZywiePro, the company’s next-generation cardiac remote monitoring system, leverages mobile and cloud technology to detect cardiovascular arrhythmias in patients in a more timely, accurate and cost-effective manner than alternative monitoring systems.

“We are helping physicians save the lives of their patients on a daily basis with our technology and monitoring service,” said Latha Ganeshan, CEO and Founder of Zywie. “It’s very gratifying to hear these success stories, and we are continuing to grow so we can bring the solution to more physicians and their patients.”

About 610,000 people die of heart disease in the United States every year–that’s 1 in every 4 deaths. With the growing number of CVD patients, a better system needed to be created to support not only these ever increasing numbers but also to provide a better tool for physicians and their staff.

Zywie helps physicians efficiently and accurately diagnose and treat their patients’ many heart-related problems. By giving physicians detailed diagnostic insight into the cardiovascular health of their patients, ZywiePro empowers physicians to provide more personalized and effective patient care.

This is the first year Venture Atlanta has included a Startup Showcase. In addition to the 35 companies that will pitch on the VA stage, the Showcase will place a spotlight on 16 early-stage businesses that are bringing big ideas to the next decade.

Related Content

Medtronic using AI to identify more TAVR patients in need
Tirzepatide linked to significant weight loss, ‘impressive’ diabetes prevention after 3 years
Most heart failure patients miss out on guideline-recommended palliative care
CMS updates outpatient reimbursement policy for Barostim device
American Heart Association announces late-breaking research for Scientific Sessions 2024
Impella ECP confirmed to be safe for high-risk PCI—is FDA approval next?

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."